Lung Cancer News

NASHVILLE, Tenn. — In this Healio exclusive, Jaspal Singh, MD, FCCP, discusses trends and advancements coming out of the CHEST Annual Meeting.

NASHVILLE, Tenn. — Lung cancer survivors had similar or increased frequency of and risk for cardiovascular comorbidities and substance abuse than patients with active lung cancer, according to a presenter at the CHEST Annual Meeting.

GENEVA — Lower BMI may increase risk for lung cancer, according to results of an ongoing prospective study presented at World Cancer Congress.

NASHVILLE, Tenn. — In this Healio exclusive, Jaspal Singh, MD, FCCP, provides his takeaways from the CHEST Annual Meeting.

NASHVILLE, Tenn. — Shape-sensing robotic-assisted bronchoscopy with cone-beam CT imaging showed promise for diagnosing central, distal-airway and peripheral pulmonary lesions in a single-center study presented at the CHEST Annual Meeting.

The presence of non-cystic fibrosis bronchiectasis increased risk for lung cancer regardless of smoking status, according to recent findings published in Annals of the American Thoracic Society.

Improving diversity in cancer clinical trial enrollment has become an increased priority among oncology researchers.

A head-to-head trial of the PD-1 inhibitors dostarlimab and pembrolizumab, each in combination with chemotherapy, met its primary endpoint of objective response rate among patients with metastatic nonsquamous non-small cell lung cancer.

The FDA granted fast track designation to sapanisertib for treatment of certain patients with non-small cell lung cancer.

The FDA granted orphan drug designation to SynKIR-110, an investigational chimeric antigen receptor T-cell therapy, for treatment of mesothelin-expressing mesothelioma.